France· FR:64520387
ANTIGONE 75 microgrammes, comprimé pelliculé
A desogestrel product containing désogestrel, registered in France by BESINS HEALTHCARE FRANCE, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Desogestrel is registered in 14 of 19 countries.
Countries holding a registration under ATC G03AC09 (desogestrel), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Desogestrel · ATC G03AC09
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- DÉSOGESTREL
- Manufacturer
- BESINS HEALTHCARE FRANCE
- Country
- France (FR)
- ATC code
- G03AC09
- ATC class
- Desogestrel
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400922474373plaquette(s) PVC-Aluminium suremballée(s)/surpochée(s) de 84 comprimé(s)EUR 2.94
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
86 interactions on record for desogestrel.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Desogestrel · interactions on record
86 records
- 5 severe
- 55 moderate
- 1 minor
Most severe, free to view
- DabrafenibL01EC02severe
- DabrafenibL01XE23severe
- BexaroteneL01XF03severe
- BexarotenL01XX25severe
25 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Desogestrel in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAZALIAGedeon Richter Plc., Budapešť
- SwitzerlandAnouk 0.075 mg, FilmtablettenSpirig HealthCare AG
- BelgiumAurodes 0.075 mgAurobindo
- PolandAzaliaDelfarma Sp. z o.o.
- United KingdomAizea 75microgram tabletsBesins Healthcare (UK) Ltd
- FinlandAzaliaOrifarm Oy
- GermanyCerazetteOrganonhealthcare Gmbh
- SpainAIACET 75 MICROGRAMOS COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Cinfa S.A.
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Cerazette, Cycle
- Belgium · Cerazette, Desirett
- Czechia · Azalia, Cerazette
- Germany · Cerazette, Chalant
- Denmark · Azalia, Ceranor
- Estonia · Cerazette, Delamonie
- Spain · Aiacet, Azalia
- Finland · Azalia, Ceranor
- United Kingdom (Northern Ireland) · Aizea, Cerazette
- Greece · Cerazette
- Hungary · Azalia, Cerazette
- Ireland · Azalia, Cerazette
- Iceland · Cerazette, Desirett
- Italy · Aimi, Azalia
- Lithuania · Azalia, Desirett
- Luxembourg · Cerazette, Desirett
- Latvia · Azalia, Desirett
- Malta · Azalia, Desogestrel Rowex
- Netherlands · Cerazette, Delamonie
- Norway · Azalia, Cerazette
- Poland · Azalia, Cerazette
- Portugal · Azalia, Cerazette
- Romania · Azalia, Cerazette
- Sweden · Azalia, Ceranor
- Slovenia · Cerazette, Cerelle
- Slovakia · Azalia, Desirett
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/51f36e5c-c622-478e-bf5c-7dc25fa599b0 GET /v1/drugs/51f36e5c-c622-478e-bf5c-7dc25fa599b0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64520387",
"date_amm": "2012-09-27",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "DÉSOGESTREL",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about desogestrel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.